Perpetuum Ventures

Foundation date

18-01-2018

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

PIONEERING PLANT SCIENCE.

Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.

Our company focuses on four R&D platforms:

  • Plant cell extraction

  • Transient expression of recombinant proteins in plants

  • Dendritic nano adjuvants

  • Biopolymer scaffolds

Upcoming events

Latest news

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Mithra announces Estelle® launch in Belgium

    Thursday October 21st 2021

  • Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes

    Wednesday October 20th 2021